CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED
31st March 2025
SUNSHINE HOLDINGS PLC
GROUP CHIEF EXECUTIVE OFFICER'S MESSAGE
Dear Shareholders,
FY25 marked a year of resilience and renewed momentum for Sunshine Holdings PLC, as we delivered steady top-line growth while continuing to invest in the long-term transformation of our core businesses. Despite macroeconomic headwinds and evolving consumer dynamics, the Group achieved strong financial results and laid critical groundwork for sustained value creation.
The Group posted a consolidated revenue of LKR 59.3 bn for FY25, reflecting a 7.0% year-on-year (YoY) growth. This performance was led by strong double-digit expansion in the Healthcare segment, which contributed 55.0% of Group revenue. The Consumer and Agribusiness sectors accounted for 31.6% and 13.4% of revenue, respectively, maintaining a balanced and diversified portfolio.
Gross profit grew 6.6% YoY to LKR 17.8 bn, with the gross margin holding steady at 30.1% in FY25 cf. 30.2% in FY24, reflecting the resilience of core operations. Increased scale in the Healthcare sector and operational efficiencies in Agribusiness supported profitability, with earnings before interest and taxes (EBIT) rising to LKR 9.3 bn, a 7.1% increase YoY. The Group maintained an EBIT margin of 15.7%, despite margin contraction in the Consumer segment.
Profit after tax (PAT) reached LKR 5.9 bn, broadly flat versus last year -1.7% YoY despite a 48.9% increase in income tax expenses stemming from changes in Agribusiness taxation, and continued margin pressures in the Consumer segment.
Financial Snapshot
4QFY25 Vs 4QFY24 FY25 Vs FY24
Following the FY25 share split (4-for-1), which improved liquidity and broadened investor access, the Group will continue to engage with the capital markets actively, with a commitment to transparency, shareholder returns, and long-term value generation.
Healthcare | 7,804 | 15.9% | 32,586 | 17.3% |
Consumer | 4,373 | -2.6% | 18,747 | -3.0% |
Agri | 1,919 | 4.4% | 7,944 | -4.5% |
Other | 2 | n/m | 5 | 2.3% |
Revenue | 14,097 | 7.9% | 59,282 | 7.0% |
Gross Profit | 3,921 | 13.1% | 17,848 | 6.6% |
GP Margin | 27.8% | +128 bps | 30.1% | -10 bps |
EBIT | 1,887 | 48.7% | 9,278 | 7.1% |
EBIT Margin | 13.4% | +367 bps | 15.7% | +2 bps |
Net Finance Cost | (79) | -74.2% | (308) | -47.9% |
Income Tax Expense | (576) | 47.2% | (3,057) | 48.9% |
PAT | 1,232 | 116.1% | 5,914 | -1.7% |
The Healthcare sector continued its trajectory of robust growth, recording double-digit revenue growth of 17.3% YoY across the pharmaceutical agency, distribution, and pharmaceutical manufacturing verticals. This topline momentum translated into improved profitability, with the sector's EBIT margin expanding to 16.9% in FY25, up from 15.5% in FY24.
The pharmaceutical agency business delivered a strong 14.3% YoY growth, fueled by sustained volume expansion across key therapeutic areas. The medical devices segment contracted by 12.8% YoY, reflecting a high base in the prior year. Adjusting for this, the underlying business posted 5.2% YoY growth, underscoring continued demand and stability in core device categories.
Healthguard Distribution expanded its portfolio by securing new distributor relationships with Cipla and Micro Labs, contributing to a 23.9% revenue increase in FY25. These partnerships are expected to bring long-term value through increased distribution capabilities, and joint business development initiatives.
Our retail arm, Healthguard Pharmacy, recorded 9.2% revenue growth YoY, driven primarily by increased prescription volumes in the pharmaceutical category. The wellness segment also contributed through value growth, despite a slight decline in volumes, reflecting stronger average spend per customer. During the year, we expanded our retail footprint to 16 outlets with the opening of a new location in Malabe, extending our reach into high-growth suburban areas.
Lina, the pharmaceutical manufacturing business, continued to scale meaningfully with a 69.2% YoY increase in revenue. This performance was led by higher output from the Metered Dose Inhaler (MDI) line, which fulfilled the entirety of the Government's MDI requirement for 2024. Lina's ability to deliver critical respiratory products at scale further reinforces its role as a key enabler of local pharmaceutical self-sufficiency.
ConsumerThe Consumer sector, comprising both export and domestic businesses, faced a challenging year, with revenue contracting by 3.0% YoY to LKR 18.7 bn, primarily due to subdued domestic demand during the first half of FY25.
Revenue from the Branded Tea and Confectionery (domestic) businesses declined by 12.7% YoY.
While the branded tea segment demonstrated resilience, confectionery volumes remained under pressure throughout the year.
Within branded tea, volumes grew by 2.2% YoY during the year, despite an 8.8% contraction in value, primarily due to VAT related pricing pressures in the first half. Amidst challenging consumer sentiment, our tea brands Watawala Thei and Ran Kahata showed resilience, though Zesta experienced a volume decline during the period.
The confectionery segment continued to be affected by weak consumer sentiment following VAT increases, alongside intensified competitive activity. These pressures contributed to a significant volume drop, translating into a 28.0% YoY revenue contraction for FY25.
However, this was partially offset by the export business, which maintained its positive momentum in FY25. Strong demand from key clients supported volume growth, resulting in a 19.1% YoY increase in export revenue.
EBIT margins for the sector came under pressure in FY25, impacted by adverse market conditions in the first half and a normalization following favorable conditions in FY24. As a result, margins contracted to 6.1%, compared to 9.7% in the previous year.
AgribusinessThe Agribusiness sector reported revenue of LKR 7.9 bn in FY25, a 4.5% decline YoY, attributable to an 18.6% drop in revenue from the dairy business.
The palm oil segment saw a 1.6% YoY decline in revenue, primarily due to lower sales volumes. While selling prices for oil and crops improved in the second half of the year, this was
Page 01
SUNSHINE HOLDINGS PLC
insufficient to offset the impact of reduced volumes.
The dairy business recorded LKR 1.2 bn in revenue, down 18.6% YoY, driven by reductions in both production volumes and realized selling prices.
Despite the topline contraction, sector profitability improved, with EBIT margin increasing to 36.2% in FY25, compared to 32.0% in the previous year. This uplift was driven by cost efficiencies in the palm oil segment.
OutlookHealthcare: Following the successful equity infusion from the International Finance Corporation (IFC), the Group will continue to accelerate the scale-up of operations at Sunshine Healthcare Lanka (SHL). Strategic investments are underway to expand Lina's manufacturing capacity, strengthen diagnostic infrastructure, and deepen retail and distribution reach. The sector remains focused on delivering accessible, high-quality healthcare while pursuing selective organic and inorganic growth opportunities across its core verticals. Continued operational discipline and innovation will be key to unlocking further efficiencies and expanding market share in FY26.
Consumer: The Group will maintain its strategic emphasis on strengthening consumer brand equity and improving route-to-market execution. While domestic demand is expected to remain sensitive to pricing, ongoing investments in product innovation and retail channel synergies will help defend market share. The export business will continue to be a primary growth engine, with efforts underway to further diversify markets and scale volumes.
Agribusiness: The Agribusiness sector is poised for a more stable year, with palm oil prices expected to remain steady and volumes increasing with greater focus on land productivity. In the dairy business, more favourable feed economics are expected to support margins.
Further details of the Group's performance are available on the
company website.
https://www.sunshineholdings.lk/investor/financial-reports
Shyam Sathasivam
Group Chief Executive Officer 28 May 2025
Colombo
Page 02
SUNSHINE HOLDINGS PLC
CONDENSED STATEMENT OF COMPREHENSIVE INCOME - GROUP
Unaudited | *Restated | Audited | Unaudited | *Restated | Unaudited | |||
Year ended | Year ended | Year ended | Quarter ended | Quarter ended | Quarter ended | |||
31 | 31 | 31 | 31 | 31 | 31 | |||
March | March | March | March | March | March | |||
2025 | 2024 | 2024 | Change | 2025 | 2024 | 2024 | Change | |
RS '000 | RS '000 | RS '000 | % | RS '000 | RS '000 | % | ||
Continuing operations | ||||||||
Revenue | 59,282,247 | 55,422,147 | 55,533,886 | 7 | 14,097,237 | 13,065,554 | 13,148,167 | 8 |
Cost of sales | (41,434,404) | (38,680,900) | (38,293,643) | 7 | (10,176,431) | (9,599,468) | (9,518,011) | 6 |
Gross profit | 17,847,843 | 16,741,247 | 17,240,243 | 7 | 3,920,806 | 3,466,086 | 3,630,156 | 13 |
Dividend Income | 61,303 | 111,740 | - | 12,680 | 82,613 | - | (85) | |
Other income | 589,893 | 326,417 | 315,094 | 81 | 286,780 | 5,978 | (5,343) | nm |
Gain/(loss) on changes in fair | ||||||||
value of biological assets | (321,221) | 39,989 | 39,989 | nm | (68,168) | 53,629 | 53,629 | nm |
Selling & distribution expenses | (5,325,073) | (5,260,705) | (5,260,705) | 1 | (1,318,500) | (1,425,308) | (1,425,308) | (7) |
Administrative expenses | (3,574,283) | (3,296,296) | (3,672,230) | 8 | (946,781) | (914,320) | (984,456) | 4 |
Results from operating activities | 9,278,462 | 8,662,392 | 8,662,392 | 7 | 1,886,817 | 1,268,678 | 1,268,678 | 49 |
Finance income | 503,253 | 577,588 | 577,588 | (13) | 111,629 | 940 | 940 | nm |
Finance cost | (810,870) | (1,168,094) | (1,168,094) | (31) | (191,003) | (308,402) | (308,402) | (38) |
Net finance cost | (307,617) | (590,506) | (590,506) | (48) | (79,374) | (307,462) | (307,462) | (74) |
Profit before tax 8,970,845 | 8,071,886 | 8,071,886 | 11 | 1,807,443 | 961,216 | 961,216 | 88 |
Income tax expense (3,056,720) | (2,052,638) | (2,052,638) | 49 | (575,500) | (391,062) | (391,063) | 47 |
Profit for the period 5,914,125 | 6,019,248 | 6,019,248 | (2) | 1,231,943 | 570,153 | 570,153 | 116 |
Other comprehensive income Equity investments at FVOCI - net change - in fair value (216,354) | 360,558 | 360,558 | (160) | (216,354) | 360,558 | 360,558 | - |
Exchange gain/(Loss) on | |||||||
foreign operation translation (410) | (3,335) | (3,335) | (88) | 323 | (2,210) | (2,210) | - |
Tax on other comprehensive income 104,980 | (101,089) | (101,089) | (204) | 104,980 | (101,089) | (101,089) | |
Remeasurement of retirement | |||||||
benefit liability (136,998) | (24,249) | (24,249) | 465 | (136,998) | (24,249) | (24,249) | - |
income for the period (248,782) | 231,885 | 231,885 | (207) | (248,049) | 233,010 | 233,010 | - |
Total comprehensive income for the period 5,665,344 | 6,251,133 | 6,251,133 | (9) | 983,894 | 803,163 | 803,163 | 23 |
Profit aflributable to: Owners of the parent company 4,239,533 | 4,471,041 | 4,471,041 | (5) | 877,140 | 508,197 | 508,197 | 73 |
Non-controlling interest 1,674,593 | 1,548,206 | 1,548,206 | 8 | 354,803 | 61,955 | 61,955 | 473 |
Other comprehensive income aflributable to: Owners of the parent company (201,252) | 238,670 | 238,670 | (184) | (200,519) | 239,796 | 239,796 | (184) |
Non-controlling interest (47,530) | (6,785) | (6,785) | - | (47,530) | (6,785) | (6,785) | |
Total comprehensive income 5,665,344 | 6,251,133 | 6,251,133 | (9) | 983,894 | 803,163 | 803,163 | 23 |
Basic earnings per share 2.15 | 2.27 | 2.27 | 0.45 | 0.26 | 0.26 |
Total other comprehensive
for the period
Figures in brackets indicate deductions.
The above figures are not audited n/m- not meaningful
* 2024 Figures have been reclassięed according to SLFRS 15 as a result of the business module change. Detailed note has provided in Note no 06.
Page 03
SUNSHINE HOLDINGS PLC CONDENSED STATEMENT OF COMPREHENSIVE INCOME - COMPANY | ||||||||||
**Amalgamated and | **Amalgamated | |||||||||
Unaudited | *Restated | Restated | Audited | Unaudited | *Restated | and Restated | Unaudited | |||
Year ended | Year ended | Year ended | Period ended | Quarter ended | Quarter ended | Quarter ended | Quarter ended | |||
31 March | 31 March | 31 March | 31 March | |||||||
31 March 2025 | 31 March 2024 | 31 March 2024 | 31 March 2024 | Change | 2025 | 2024 | 2024 | 2024 | Change | |
RS '000 | RS '000 | RS '000 | RS '000 | % | RS '000 | RS '000 | RS '000 | RS '000 | % | |
Revenue | 749,840 | 452,869 | 475,158 | 2,070,290 | 58 | 197,436 | 121,075 | 126,841 | 507,665 | 56 |
Cost of sales | (730,870) | (387,258) | (387,258) | - | 89 | (248,002) | (83,668) | (83,667) | - | 196 |
Gross profit | 18,970 | 65,611 | 87,900 | 2,070,290 | (78) | (50,565) | 37,408 | 43,174 | 507,665 | (217) |
Dividend income | 2,395,266 | 2,070,290 | 2,070,290 | - | 16 | 427,282 | 507,664 | 507,664 | - | (16) |
Other income | 129,410 | 48,421 | 50,364 | 489,969 | 157 | 86,653 | 20,402 | 21,265 | 130,156 | 307 |
Administrative expenses | (424,765) | (367,982) | (359,349) | (743,919) | 13 | (94,974) | (196,089) | (182,310) | (268,434) | (52) |
Results from operating activities | 2,118,881 | 1,816,340 | 1,849,206 | 1,816,340 | 16 | 368,396 | 369,386 | 389,792 | 369,385 | (2) |
Finance income | 96,212 | 159,616 | 139,246 | 159,616 | (31) | 27,406 | 40,800 | 33,179 | 40,800 | (17) |
Finance cost | (4,321) | (1,217) | (1,217) | (1,217) | 255 | 503 | (45) | (45) | (46) | (1,214) |
Net finance cost 91,891 | 158,399 | 138,028 | 158,399 | (33) | 27,909 | 40,755 | 33,134 | 40,754 | (16) | |
Profit before tax 2,210,772 | 1,974,739 | 1,987,234 | 1,974,739 | 12 | 396,308 | 410,140 | 422,925 | 410,139 | (3) | |
Income tax expense 32,923 | 17,289 | 17,289 | 17,289 | 90 | 32,299 | 10,602 | 10,602 | 10,602 | 205 | |
Profit for the period 2,243,695 | 1,992,029 | 2,004,523 | 1,992,029 | 13 | 428,608 | 420,742 | 433,527 | 420,741 | 2 | |
Other comprehensive income Equity investments at FVOCI - net change (216,354) in fair value | 360,558 | 360,558 | 360,558 | - | (216,354) | 360,558 | 360,558 | 360,558 | - | |
Relax Tax 61,853 | (105,565) | (105,565) | (105,565) | - | 61,853 | (105,565) | (105,565) | (105,565) | - | |
Defined benefit plan actuarial gain/(loss) 10,176 | (8,673) | (8,673) | (8,673) | - | 10,176 | (8,673) | (8,673) | (8,673) | - | |
Total other comprehensive income for the period (144,325) | 246,320 | 246,320 | 246,320 | - | (144,325) | 246,320 | 246,320 | 246,320 | - | |
Total comprehensive income for the period 2,099,370 | 2,238,349 | 2,250,843 | 2,238,349 | (6) | 284,283 | 667,062 | 679,847 | 667,061 | (57) | |
Basic earnings per share from continuing operations 1.14 | 1.01 | 1.02 | 1.01 | 0.22 | 0.21 | 0.22 | 0.21 | |||
Figures in brackets indicate deductions.
* 2024 Figures have been reclassified according to SLFRS 15 as a result of the business module change. Detailed note has provided in Note no 06.
** Sunshine Packaging lanka Limited has amalgamated with Sunshine Holdings PLC and figures prasented accordingly. Detailed note has provided in Note no 7.5.
Page 04
SUNSHINE HOLDINGS PLC
STATEMENT OF FINANCIAL POSITION - GROUP
Unaudited Audited
As at 31st March 2025 RS '000 | As at 31st March 2024 RS '000 | |
ASSETS | ||
Non current assets | ||
Property, plant and equipment | 6,828,565 | 6,641,907 |
Intangible assets | 235,132 | 277,903 |
Leasehold right to bare land | 409,805 | 359,851 |
Biological assets | 3,317,573 | 3,658,653 |
Investment property | 570,199 | 631,212 |
Other investments | 578,045 | 833,617 |
Deferred tax assets | 374,924 | 420,127 |
Goodwill on Acquisition | 1,310,733 | 1,387,106 |
Total non-current assets | 13,624,976 | 14,210,376 |
Current assets | ||
Biological assets-growing crops on bearer plants | 36,510 | 70,867 |
Inventories | 13,860,452 | 12,063,288 |
Other investments | 4,489,534 | 1,770,256 |
Current tax assets | 143,552 | 139,136 |
Trade & other receivables | 9,796,632 | 9,782,520 |
Amounts due from related parties | 326,356 | 31,747 |
Cash & cash equivalent | 5,875,414 | 5,403,789 |
Total current assets | 34,528,450 | 29,261,603 |
Total assets | 48,153,426 | 43,471,979 |
EQUITY AND LIABILITIES | ||
Equity | ||
Stated capital | 4,240,394 | 4,240,394 |
Reserves | 92,933 | 430,473 |
Retained earnings | 15,965,699 | 14,233,958 |
Equity aflributable to owners of the company | 20,299,026 | 18,904,825 |
Non-controlling interests | 6,748,189 | 3,767,868 |
Total equity | 27,047,215 | 22,672,693 |
Non-current liabilities | ||
Loans and borrowings | 1,948,938 | 1,676,016 |
Employee benefits | 1,221,861 | 1,009,377 |
Deferred income and capital grants | 34,173 | 36,726 |
Deferred tax | 1,610,069 | 1,686,737 |
Total non-current liabilities | 4,815,041 | 4,408,856 |
Current liabilities | ||
Trade and other payables | 9,209,949 | 7,603,511 |
Current tax liabilities | 1,410,124 | 785,681 |
Loans and borrowings | 4,921,953 | 5,311,993 |
Bank overdraft | 749,144 | 2,689,245 |
Total current liabilities | 16,291,170 | 16,390,430 |
Total equity and liabilities | 48,153,426 | 43,471,979 |
Net asset value per share (Rs.) | 10.32 | 9.61 |
The above figures are not audited |
It is certified that the Financial Statements have been prepared in compliance with the requirements of the Companies
Act No. 7 of 2007.
Group Chief Financial Officer
The Board of Directors is responsible for the preparation and presentation of these financial statements. Approved and signed for and on behalf of the Board.
Chairman Group Chief Executive Officer
May 28th, 2025
Colombo
Page 05
SUNSHINE HOLDINGS PLC STATEMENT OF FINANCIAL POSITION - COMPANY | |||
Unaudited | **Amalgamated | Audited | |
As at 31 March 2025 | As at 31 March 2024 | As at 31 March 2024 | |
RS '000 | RS '000 | RS '000 | |
ASSETS | |||
Non-current assets | |||
Property, Plant and Equipment | 61,714 | 8,652 | 8,652 |
Intangible assets | 9,796 | 14,490 | 14,490 |
Investment property | 901,730 | 845,658 | - |
Investment in subsidiaries | 7,325,815 | 7,325,815 | 7,747,698 |
Other investments | 572,918 | 782,224 | 782,224 |
Deferred tax assets | 14,689 | 31,602 | 31,602 |
Total non-current assets | 8,886,662 | 9,008,441 | 8,584,666 |
Current assets | |||
Inventories | - | 296 | 296 |
Current tax assets | 97,667 | 75,566 | 75,566 |
Trade & other receivables | 18,193 | 72,132 | 44,017 |
Amounts due from related parties | 9,459 | 26,192 | 257,990 |
Other Short Term Investments | 1,890,123 | 846,226 | 846,226 |
Cash & cash equivalent | 288,928 | 734,571 | 723,291 |
Total current assets | 2,304,370 | 1,754,983 | 1,947,386 |
Total assets | 11,191,032 | 10,763,424 | 10,532,052 |
EQUITY AND LIABILITIES | |||
Equity | |||
Stated capital | 4,240,394 | 4,240,394 | 4,240,394 |
Reserves | 286,264 | 430,590 | 430,590 |
Retained earnings | 6,211,099 | 5,689,313 | 5,572,519 |
Equity aflributable to owners of the company | 10,737,757 | 10,360,297 | 10,243,503 |
Non-controlling interests | - | - | - |
Total equity | 10,737,757 | 10,360,297 | 10,243,503 |
Non-current liabilities | |||
Loans and borrowings | - | - | - |
Deferred tax liability | - | 111,689 | - |
Employee benefits | 229,653 | 190,922 | 190,922 |
Total non-current liabilities | 229,653 | 302,611 | 190,922 |
Current liabilities | |||
Trade and other payables | 193,857 | 100,234 | 97,345 |
Amounts due to related parties | 2 | 282 | 282 |
Loans and borrowings | 29,763 | - | - |
Total current liabilities | 223,622 | 100,516 | 97,627 |
Total equity and liabilities | 11,191,032 | 10,763,424 | 10,532,052 |
Net asset value per share (Rs.) | 5.46 | 5.26 | 5.21 |
The above figures are not audited
** Sunshine Packaging lanka Limited has amalgamated with Sunshine Holdings PLC and figures prasented accordingly. Detailed note has provided in Note no 7.5.
It is certified that the Financial Statements have been prepared in compliance with the requirements of the Companies Act No. 7 of 2007.
Group Chief Financial Officer
The Board of Directors is responsible for the preparation and presentation of these financial statements. Approved and signed for and on behalf of the Board.
Chairman Group Chief Executive Officer
May 28th, 2025 Colombo
Page 06
SUNSHINE HOLDINGS PLC
FOR THE QUARTER ENDED 31ST MARCH 2025
CONDENSED STATEMENT OF CHANGES IN EQUITY - GROUP
Aflributable to owners of the company
In RS '000 | Stated capital | Reserve on exchange gain or loss | General reserve | Fair value gain or loss reserve on AFS | Retained earnings | Total | Non-controlling interest | Total equity |
Balance as at 1st April 2023 | 4,240,394 | 4,935 | 1,258 | 185,609 | 11,356,302 | 15,788,499 | 3,448,610 | 19,237,110 |
Total Comprehensive Income | ||||||||
Profit for the year | - | - | - | - | 4,471,041 | 4,471,041 | 1,548,206 | 6,019,247 |
Total other comprehensive income for the year | - | (3,335) | - | 242,006 | - | 238,670 | (6,785) | 231,885 |
Total comprehensive income for the year | - | (3,335) | - | 242,006 | 4,471,041 | 4,709,711 | 1,541,421 | 6,251,132 |
Dividend paid to owners for 2022/23 | - | - | - | - | (565,770) | (565,770) | - | (565,770) |
Dividend paid to owners for 2023/24 | - | - | - | - | (491,974) | (491,974) | (1,365,219) | (1,857,193) |
WHT payment on dividend distribution | - | - | - | - | (438,724) | (438,724) | (46,862) | (485,586) |
Lina Manufacturing (Pvt) Ltd and Lina Spiro (Pvt) Ltd Share Swap | - | - | - | - | (96,918) | (96,918) | 189,918 | 93,000 |
Balance as at 31st March 2024 | 4,240,394 | 1,600 | 1,258 | 427,615 | 14,233,958 | 18,904,825 | 3,767,868 | 22,672,693 |
Balance as at 1st April 2024 | 4,240,394 | 1,600 | 1,258 | 427,615 | 14,233,958 | 18,904,825 | 3,767,868 | 22,672,693 |
Total Comprehensive Income | ||||||||
Profit for the year | - | - | - | 4,239,533 | 4,239,533 | 1,674,593 | 5,914,125 | |
Total other comprehensive income for the year | (410) | - | (200,842) | - | (201,252) | (47,530) | (248,782) | |
Total comprehensive income for the year Dividend paid to owners for 2023/24 | (410) | - - | (200,842) - | 4,239,533 (983,947) | 4,038,281 (983,947) | 1,627,063 (793,711) | 5,665,344 (1,777,658) | |
Dividend paid to owners for 2024/25 | - | - | - | - | (737,960) | (737,960) | (1,208,300) | (1,946,260) |
Adjustment for Investment property | - | - | - | (136,287) | - | (136,287) | - | (136,287) |
Share issue to IFC | - | - | - | - | - | - | 3,270,000 | 3,270,000 |
Share issue cost to IFC | - | - | - | - | (60,658) | (60,658) | - | (60,658) |
Share isuued by Lina Manufacturing Pvt Ltd to NCI | - | - | - | - | 256,827 | 256,827 | ||
Reversal of Dividend payable | - | - | - | - | 7,680 | 7,680 | 7,680 | |
Equity adjustment on changes in holding in Lina Manufacturing Pvt Ltd | - | - | - | - | 16,390 | 16,390 | (16,390) | - |
WHT payment on dividend distribution | - | - | - | - | (749,297) | (749,297) | (155,168) | (904,465) |
Balance as at 31st March 2025 | 4,240,394 | 1,190 | 1,258 | 291,328 | 15,965,699 | 20,299,026 | 6,748,189 | 27,047,215 |
The above figures are not audited |
Page 07
SUNSHINE HOLDINGS PLC
FOR THE YEAR ENDED 31ST MARCH 2025
STATEMENT OF CHANGES IN EQUITY - COMPANY In RS '000 | Stated capital | Fair valuegain or loss reserve on AFS | General reserve | Retained earnings | Total |
Balance as at 1 April 2023 | 4,240,394 | 183,012 | 1,258 | 4,638,236 | 9,062,900 |
Amalgamation adjustment | - | - | - | 104,296 | 104,296 |
Adjusted balance as at 1st April 2023 | 4,240,394 | 183,012 | 1,258 | 4,742,533 | 9,167,196 |
Total comprehensive income for the year | |||||
Profit for the year | - | - | - | 2,004,522 | 2,004,522 |
Total other comprehensive income for the year | - | 246,320 | - | - | 246,320 |
Total comprehensive income for the year | - | 246,320 | - | 2,004,522 | 2,250,842 |
Amalgamation adjustment | 15,034 | 15,034 | |||
Dividend to owners - 2022/23 | - | - | - | (565,770) | (565,770) |
Dividend to owners - 2023/24 | - | - | - | (491,974) | (491,974) |
Balance as at 31st March 2024 | 4,240,394 | 429,332 | 1,258 | 5,689,311 | 10,360,294 |
Balance as at 1 April 2024 | 4,240,394 | 429,332 | 1,258 | 5,689,311 | 10,360,294 |
Total comprehensive income for the period | |||||
Profit for nine months | - | - | - | 2,243,695 | 2,243,695 |
Total other comprehensive income for the year | - | (144,325) | - | - | (144,325) |
Total comprehensive income for the year | - | (144,325) | - | 2,243,695 | 2,099,370 |
Dividend to owners - 2023/24 | - | - | - | (983,947) | (983,947) |
Dividend to owners - 2024/25 | - | - | - | (737,960) | (737,960) |
Balance as at 31st March 2025 | 4,240,394 | 285,007 | 1,258 | 6,211,099 | 10,737,757 |
The above figures are not audited |
Page 08
SUNSHINE HOLDINGS PLC | ||
Unaudited | Audited | |
STATEMENT OF CASH FLOWS - GROUP | Year ended 31 March 2025 | Year ended 31 March 2024 |
RS '000 | RS '000 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Profit before income tax | 8,970,845 | 8,071,886 |
Adjustments for; Interest Income | (390,506) | (525,313) |
Profit on Disposal of Property, Plant & Equipment | (80,746) | 2,221 |
Fair value changes in livestock | - | (29,431) |
Interest Expense | 809,228 | 980,115 |
Reversal of Impairement of Investment in Subsidiary Depreciation of Property, Plant and Equipment
-
746,069
Amortization of Intangible Assets | 176,423 | 92,214 |
Depreciation of mature planations | 306,685 | 179,312 |
Provision/(Reversal) for Bad and Doubtful Debts | (8,718) | 318,629 |
Provision/ (Reversal) of impairment of inventories | (2,553) | 103,939 |
Amortisation of Deferred Income | 20,875 | (2,358) |
72,565
-
771,098
Amortization of Lesehold land right Fair value gain/loss on investments
(49,464)
76,373
(10,818)
17,536
6,352
Provision for Gratuity excluding acturial gain/loss | 216,040 | 235,618 |
Fair value gain/loss on Consumer Biological Assets | 321,222 | (10,558) |
Operating profit before working capital changes | 11,173,520 | 10,211,260 |
(Increase)/decrease in inventories | (1,788,446) | (2,306,107) |
(Increase)/decrease in trade and other receivables | (320,797) | (2,208,854) |
(Increase)/decrease in amounts due from related parties | (294,607) | 117,693 |
Increase/(decrease) in trade and other payables | 1,606,444 | 1,179,565 |
Increase/(decrease) in amounts due to related parties | - | (55,000) |
Cash generated from/ (used in) operations | 10,376,114 | 6,938,557 |
Interest paid | (352,110) | (494,687) |
Income tax paid | (3,373,543) | (2,226,548) |
Gratuity paid | (140,555) | (133,626) |
6,509,906 | 4,083,694 | |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Interest Received | 390,130 | 525,313 |
(Investments)/ Disposal in Other Investments | (2,011,109) | 882,237 |
(Investments)/ Disposal in Short term Investments | (491,779) | (1,540,386) |
(Investments)/ Disposal in gratuity fund | 50,000 | 9,000 |
Additions to Bearer plants | (34,077) | (36,021) |
Additions of live stock | (186,813) | (306,209) |
Acquisition of PPE | (1,010,352) | (709,789) |
Acquisition of Intangible Assets | (32,764) | (21,006) |
Proceeds from Disposal of PPE | 177,961 | 30,121 |
Proceeds from sales of livestock | 98,682 | 63,122 |
Proceeds from share Issued by subsidiaries to NCI | 3,209,341 | 93,000 |
Disposal of investment property | 94,534 | - |
Acquisition of Investment property | (3,693) | (3,685) |
Net cash generated from / (used in) Investing activities | 250,061 | (1,014,303) |
CASH FLOWS FROM FINANCING ACTIVITIES
Receipts of Interest Bearing Borrowings
Proceeds from share Issued by subsidiaries to NCI
20,009,180
-
4,195,897
-
Repayments of Interest Bearing Borrowings | (19,629,452) | (2,958,226) |
Payment to lease creditor | (867,763) | (167,853) |
Dividend Paid | (3,723,918) | (2,422,963) |
Net cash from / (used in) financing activities | (4,211,953) | (1,353,145) |
Net increase/(decrease) in cash and cash equivalents | 2,548,014 | 1,716,247 |
Cash and cash equivalents at the beginning of the period | 2,714,544 | 1,001,633 |
Effect of exchange rate changes on cash and cash equivalents | (136,287) | (3,335) |
Cash and cash equivalents at the end of the period | 5,126,271 | 2,714,544 |
Cash and cash equivalents Cash in hand & bank | 5,875,414 | (2,689,245) |
Bank overdraft | (749,144) | 5,403,789 |
5,126,271 | 2,714,544 | |
Figures in brackets indicate deductions. | ||
The above figures are not audited | ||
Page 09 |
SUNSHINE HOLDINGS PLC STATEMENT OF CASH FLOWS - COMPANY | Unaudited | Unaudited | Audited |
Period ended | Period ended | Year ended | |
31st March 2025 LKR '000 | 31st March 2024 RS '000 | 31st March 2024 LKR '000 | |
CASH FLOWS FROM OPERATING ACTIVITIES |
2,210,772 | 1,987,233 | 1,974,740 |
(96,212) | (159,616) | (159,616) |
Interest expense | 4,321 | 21,588 | 1,218 |
Amalgamation of SPL | - | - | - |
Fair Value of Investment property | (56,072) | - | (56,072) |
Impairment of Intercompany Loan | - | - | 14,000 |
Impairement of Investment in Subsidiary | - | - | 1,034 |
Depreciation of Property, Plant and Equipment 36,525 Amortization of Intangible Assets - | 28,112 - | 28,113 - | |
49,429 | 40,992 | 40,993 | |
Operating profit before working capital changes | 2,148,764 | 1,931,773 | 1,913,944 |
(Increase)/decrease in trade and other receivables | 53,940 | (19,383) | (15,883) |
(Increase)/Decrease in Inventory | 296 | 1,587 | 1,587 |
(Increase)/decrease in amounts due from related parties | 16,733 | (24,038) | (38,122) |
Increase/(decrease) in trade and other payables | 93,621 | 59,875 | 63,187 |
Increase/(decrease) in amounts due to related parties | (280) | 269 | 269 |
Cash generated from/ (used in) operations | 2,313,074 | 1,926,085 | 1,924,982 |
Interest paid | (4,321) | (6,023) | (270) |
Income tax paid | (22,101) | - | - |
Employee benefits paid | (523) | - | - |
Net cash generated from / (used in) operating activities | 2,286,129 | 1,920,061 | 1,914,712 |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Interest received | 100,473 | 153,359 | 153,359 |
Investments in subsidiaries | - | (500,000) | (500,000) |
(Investments)/ Disposal of Quoted shares | 7,549 | - | - |
(Investments)/ Disposal of Quoted shares | (14,634) | - | - |
Acquisition of Investement Property | - | (3,680) | - |
Disposal of Subsidiary (net of cash) | - | - | - |
Proceeds on disposal of shares held in subsidiary | |||
(Investments)/ Disposal in Short term Investments | (1,041,510) | (574,364) | (574,364) |
(Investments)/ disposal in other investments | - | - | - |
Acquisition of intangible assets | (610) | - | - |
Proceed from disposal of property, plant & equipment | 737 | - | - |
Acquisition of property, plant & equipment | (34,706) | (5,973) | (5,973) |
Net cash used in investing activities | (982,700) | (930,657) | (926,978) |
CASH FLOWS FROM FINANCING ACTIVITIES | |||
Payment of lease liabilities | (27,163) | (20,724) | (20,724) |
Dividend paid | (1,721,908) | (1,057,744) | (1,057,744) |
Net Cash generated from / (used in) Financing Activities | (1,749,071) | (1,078,468) | (1,078,468) |
Net increase/(decrease) in cash and cash equivalents | (445,643) | (89,069) | (90,733) |
Cash and cash equivalents at the beginning of the period | 734,571 | 823,640 | 814,025 |
Cash and cash equivalents at the end of the period | 288,928 | 734,571 | 723,292 |
Cash and cash equivalents Cash in hand & bank | 288,928 | 734,571 | 723,291 |
Bank overdraft | - | - | - |
Fair value gain/ loss in quoted shares and unit trust
- 13,462
13,462
Provision for gratuity
Figures in brackets indicate deductions. The above figures are not audited
288,928 734,571 723,291Page 10
SUNSHINE HOLDINGS PLC SEGMENTAL ANALYSIS
FOR THE QUARTER ENDED 31ST MARCH 2024
Healthcare Agri Consumer Goods
Other Intragroup Group
Restated Restated Restated
RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | ||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||
REVENUE | 32,586,050 | 27,772,530 | 7,944,206 | 8,320,903 | 18,746,678 | 19,323,519 | 3,674,783 | 2,072,149 | (3,669,471) | (2,066,954) | 59,282,247 | 55,422,147 | |
RESULT | |||||||||||||
Profit from operating activities | 5,518,303 | 4,298,826 | 2,873,943 | 2,660,713 | 1,150,449 | 1,873,889 | 5,067,236 | 3,426,998 | (5,331,466) | (3,598,034) | 9,278,463 | 8,662,393 | |
Net finance cost | (189,351) | (520,419) | 24,579 | 105,132 | (254,590) | (340,127) | 104,498 | 161,628 | 7,248 | - | (307,617) | (590,506) | |
Income tax expense | (1,750,515) | (1,249,614) | (1,013,613) | (421,110) | (312,507) | (389,709) | 19,916 | 7,794 | - | - | (3,056,720) | (2,052,638) | |
Profit for the year | 3,578,437 | 2,528,793 | 1,884,909 | 2,344,736 | 583,351 | 1,144,053 | 5,191,650 | 761,169 | (5,299,328) | (3,598,034) | 5,914,127 | 6,019,249 | |
Other comprehensive income | (27,548) | (11,913.92) | (69,880) | (10,699.69) | (7,030) | 8,178 | (144,325) | 246,320 | - | - | (248,782) | 231,885 | |
Total comprehensive income | 3,550,889 | 2,516,879 | 1,815,029 | 2,334,036 | 576,321 | 1,152,231 | 5,047,325 | 761,169 | (5,324,218) | (3,598,034) | 5,665,345 | 6,251,133 | |
OTHER INFORMATION | |||||||||||||
Healthcare Agri Consumer Goods Other | |||||||||||||
RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | ||
31/03/2025 | 31/3/2024 | 31/03/2025 | 31/3/2024 | 31/03/2025 | 31/3/2024 | 31/03/2025 | 31/3/2024 | 31/03/2025 | 31/3/2024 | 31/03/2025 | 31/3/2024 | ||
Segment assets | 25,004,337 | 20,666,686 | 8,713,149 | 9,431,315 | 9,719,932 | 9,079,745 | 15,956,259 | 15,341,389 | (11,240,250) | (11,047,156) | 48,153,426 | 43,471,979 | |
Equity & reserves | 14,086,040 | 8,455,982 | 3,747,238 | 6,397,322 | 4,966,815 | 3,930,451 | 15,437,078 | 14,633,543 | (11,189,959) | (10,744,607) | 27,047,215 | 22,672,693 | |
Total liabilities | 10,918,297 | 12,210,704 | 4,965,911 | 3,033,993 | 4,753,117 | 5,149,294 | 519,182 | 707,846 | (50,291) | (302,549) | 21,106,211 | 20,799,286 | |
RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | RS '000 | ||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||
Depreciation | 324,000 | 327,656 | 419,905 | 411,783 | 234,433 | 247,823 | 40,281 | 29,430 | - | - | 1,018,618 | 1,016,692 | |
Capital expenditure | 746,295 | 290,026 | 444,902 | 697,593 | 235,408 | 174,229 | 90,815 | 5,914 | - | - | 1,517,421 | 1,167,762 | |
Figures in brackets indicate deductions | . | ||||||||||||
The above figures are not audited | |||||||||||||
Page 11
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
-
Corporate information
Sunshine Holdings PLC (the "Company") is a Company incorporated and domiciled in Sri Lanka. The ordinary shares of the Company are listed on Colombo Stock Exchange of Sri Lanka. The address of the Company's registered office is no. 60, Dharmapala Mawatha, Colombo 03, Sri Lanka.
The Group is primarily involved in managing portfolio of investments which includes manufacturing, importing and selling of pharmaceuticals & medical devices, selling and export of branded tea, manufacturing of confectionery, fresh milk, palm oil and related products.
-
Interim condensed financial statements
The Interim Condensed Financial Statements for the year ended 31st March 2025, includes the "Company" referring to Sunshine Holdings PLC as the holding Company and the "Group" comprise the Company and subsidiary companies of Sunshine Consumer Lanka Limited (SCL) and its subsidiaries, Sunshine Healthcare Lanka Limited (SHL) and its subsidiaries, and its subsidiary, Sunshine Wilmar (Pvt) Ltd (SWPL) and its subsidiaries.
The ultimate parent of the company is Lamurep Investments Limited which holds 55.18% of the issued share capital of the company as at 31st March 2025.
-
Approval of financial statements
The Interim Condensed Financial Statements of the Group and the Company for the period ended 31st March 2025, were authorised for issue by the Board of Directors on 28th May 2025.
-
Basis of preparation
The Interim Condensed Consolidated Financial Statements have been prepared in accordance with the Sri Lanka Accounting Standards with effect from 01 January 2014 (SLFRS/LKAS). There were no changes to the accounting policies and methods of computation since the publication of the Annual Report 2023/24. Further, these Financial Statements have been prepared in compliance with the requirement of the Sri Lanka Accounting Standard - LKAS 34 on "Interim Financial Reporting".
The Interim Condensed Consolidated Financial Statements do not include all the information and disclosures required in the Annual Financial Statements, and should be read in conjunction with the Group's annual Consolidated Financial Statements as at 31 March 2024.
Previous period figures and phrases have been rearranged
wherever necessary to conform to the current presentation.
-
Significant Accounting Policies
The accounting policies applied in these interim financial statements are the same as those applied in the Group's consolidated financial statements as at and for the year ended 31 March 2024.
-
Standards Issued but not yet Effective
A number of new standards and amendments to standards are
effective for annual periods beginning after 1 April 2024 and early
application is permitted; however the Group has not early adopted any of the forthcoming new or amended standards in preparing these condensed consolidated interim financial statements.
-
Basis of Consolidation
Subsidiaries are those entities controlled by the Group. Control is the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities. In assessing control, the Group takes in to consideration that substantive rights that give the ability to direct the activities of the subsidiaries.
The Financial Statements of the subsidiaries are included in the Consolidated Financial Statements from the date the control effectively commences until the date that control effectively ceases. Non- controlling interest is measured at the proportionate share of the acquiree's identifiable net assets. A change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction.
-
Use of judgements and estimates
In preparing these interim condensed financial statements, management has made judgements and estimates that affected the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. Actual results may differ these estimates.
The significant judgments made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those described in the last annual financial statements.
-
Property, Plant & equipment Recognition and measurement
Property, plant and equipment is recorded at cost less accumulated depreciation and accumulated impairment losses if any, whilst land is measured at fair value.
De-recognitionThe carrying amount of an item of Property, plant & equipment is de-recognised on disposal; or when no future economic benefits are expected from its use. Gains and losses on de-recognition are recognised in income statement and gains are not classified as revenue. When re-valued assets are sold, any related amount included in the revaluation reserve is transferred to Retained Earnings.
DepreciationDepreciation is recognised in income statement on a straight-line basis over the estimated useful lives of each part of an item of property, plant & equipment.
-
Impairment
The Board of Directors has assessed the potential impairment loss of the property, plant and equipment as at 31 March 2025. Based on the assessment, no impairment provision is required to be made in the financial statements as at the reporting date.
-
Impairment
-
Biological assets
The Group recognise the biological assets when, and only when,
Page 12
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
the Company controls the assets as a result of past events, it is probable that future economic benefits associated with the assets will flow to the entity and fair value or cost of the assets can be measured reliably.
Bearer biological assetsTea, rubber, oil palm, cinnamon ,sundry crops and nurseries are classified as bearer biological assets. The bearer biological assets are measured at cost less accumulated depreciation and accumulated impairment losses, if any, in terms of Sri Lanka Accounting Standard LKAS 16 - Property Plant and Equipment as per the ruling issued by Institute of Chartered Accountants of Sri Lanka.
Consumable biological assetsTimber plantation is classified as consumable biological assets and is measured on initial recognition and at the end of each reporting period at fair value less cost to sell. Costs to sell include all costs that would be necessary to sell the assets, including transportation costs. The fair value of trees younger than five years cannot be reliably estimated and are carried at cost less impairment. The cost includes direct material, direct labour and appropriate proportion of directly attributable overheads. Gains or losses arising on initial recognition of timber plantations at fair values less costs to sell and from the change in fair values less costs of plantations at each reporting date are included in profit or loss for the period in which they arise. All costs incurred in maintaining the assets are included in Profit or Loss for the period in which they arise.
LivestockLivestock is measured at their fair value less estimated point of sale costs. Changes in fair value of livestock are recognised in the income statement.
-
Investment properties
Investment properties are measured initially at cost, including transaction costs. The carrying value of an investment property includes the cost of replacing part of an existing investment property, at the time that cost is incurred if the recognition criteria are met, and excludes the costs of day to- day servicing of the investment property. Subsequent to initial recognition, the investment properties are stated at fair values, which reflect market conditions at the reporting date. Gains or losses arising from changes in fair value are included in the income statement in the year in which they arise. Fair values are evaluated at least every 3 years by an accredited external, independent valuer. Investment properties are derecognised when disposed, or permanently withdrawn from use because no future economic benefits are expected. Any gains or losses on retirement or disposal are recognised in the income statement in the year of retirement or disposal.
5.7 InventoriesInventoraies other than produce stock and nurseries are stated at the lower of cost or net realisable value, after making due allowances for obsolete and slow moving items. The Group uses weighted average cost formula and actual cost in assigning the cost of inventories. The cost includes expenses in acquiring stocks, production and conversion cost and other costs incurred in bringing them to their existing location and condition.
-
Standards Issued but not yet Effective
-
Revenue
Revenue recognition under SLFRS 15 is based on the nature and timing of satisfaction of performance obligations, including significant payment terms.
SLFRS 15 - Revenue from contracts with customers, establishes a comprehensive framework for determining whether, how much and when revenue is recognised. The Group recognises revenue when a customer obtains control of the goods or services. Judgement is used to determine the timing of transfer of control -at a point in time or over the time.
-
Shared Service Income
Presently the company's primary business activity is providing shared services to the group. Accordingly company has reclassified the revenue stream. This change aligns with the Company's evolving business model and provides a clearer and more accurate representation of its business activities. Accordingly, Rs. 723Mn (2023/24 - Rs. 453 Mn) shared service charge has been identified as revneue of the company. The dividend income of Rs.2,395 Mn (2023/24 - 2,070 Mn ) has been recognized under other income.
-
Agri Business
Customers obtain the control of the produce after the customer acknowledgement at the dispatch point. Revenue is recognized point in time, at the time of dispatch after the customer acknowledgement.
-
Consumer
Customers obtain control of the goods sold when the goods are delivered to and have been accepted at their premises. Invoices are generated at that point in time. Revenue is recognized when a customer obtains control of the goods or services. Determining the timing of the transfer of control is at a point in time.
-
Healthcare
Customers obtain control of the goods sold when the goods are delivered to and have been accepted at their premises. Invoices are generated at that point in time. Revenue is recognized when a customer obtains control of the goods or services. Determining the timing of the transfer of control is at a point in time.
-
Sunshine Tea
This includes income of tea export to different countries. Revenue is recognised point in time, at the time of dispatch after the customer acknowledgement.
- Rent income
This includes rental income earned from renting out investment property owned by the Company and it's Subsidiary. Revenue is recognized over time as the rent income is recognized on a straight line basis over the term of the agreement.
6.1 Disaggregation of Revenue from Contracts with CustomersThe disaggregation of revenue has been provided under segmental analysis.
-
Shared Service Income
- Investments in subsidiaries
Quoted and unquoted investments in shares held on long term basis by the Company and Group are stated at cost less provision for diminution in value of investments.
Page 13
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
-
Change In NCI during FY 2023/24
Below NCI changes have been occurred during FY 2023/24.
On August 03, 2023, LMPL, which is a subsidiary of SHL, became a 100% ownership of Lina Spiro (Private) Limited (LSPL) with the acquisition of remaining Non-Controlling Interest of 49%. The consideration for this purchase was satisfied by the issuance of new ordinary (voting - removed) shares in LMPL to Celogen for a consideration of Rs.307 million. As a result of this transaction, the effective shareholding in LMPL held by the SHL diluted from 90.62% to 71.6%.
- Change In NCI during FY 2024/25
On May 6, 2024, International Finance Corporation (IFC) invested a total of LKR 3,269,999,800 in SHL. In consideration of this investment, SHL issued 1,905,239 ordinary voting shares to IFC on October 3, 2024. Following this transaction, SUN now holds 85.27% of the shareholding in SHL, while IFC holds the remaining 14.73%.
On February 6, 2025, Lina Manufacturing (Pvt) Ltd issued 34,253,355 shares to Sunshine Healthcare Lanka Ltd for Rs. 875 million and 10,051,929 shares to Celegon Lanka (Pvt) Ltd for Rs. 257 million. As a result of this transaction, Sunshine Healthcare Lanka Ltd.'s effective shareholding in LMPL increased from 71.6% to 74%.
-
Investment in a Subsidiary during FY 2023/24
The board of directors of SUN at the meeting held on 18 January 2024 resolved to infuse a sum of Sri Lanka Rupees Five Hundred Million (Rs. 500,000,000/-) into the capital of it's subsidiary SST. SST accordingly capitalized such sum of Sri Lanka Rupees Five Hundred Million (Rs. 500,000,000/-) by the issue of fully paid ordinary shares to the Company.
-
Investment in a Subsidiary during FY 2024/25
On February 6, 2025, Healthguard Pharmacy Ltd issued 12,500,000 shares Sunshine Healthcare Lanka Ltd for Rs. 400 million. Healthguard Pharmacy Ltd. is a fully owned subsidiary of Sunshine Healthcare Lanka Ltd.
-
Amalgamation of Subsidiary during FY 2023/24
Gordon Frazer & Bosanquate Skrine company Ltd was amalgamated with SST a fully owned subsidiary of SST with effect from 27 September 2023. Accordingly, the book value of Gordon Frazer & Bosanquate Skrine company Ltd was amalgamated with SST and SST continues as the surviving entity.
- Amalgamation of Subsidiary during FY 2024/25
SUN has amalgamated with SPL, a fully owned subsidiary of SUN effective from 01st October 2024.Accordingly, the book value of SPL was amalgamated with SUN and SUN continues as the surviving entity.
On 31st December 2024, SUN has transfered its shareholding in SST, a wholly-owned subsidiary, to SCL, wholly-owned subsidiary of the company. The transaction involves the transfer of 4,716,545 shares in SST, valued at a total consideration of LKR 1,940,000,000. As consideration for the transfer, SCL issued 31,219,826 new shares amounting to LKR 1,940,000,000 to SUN.
Page 14
SUNSHINE HOLDINGS PLC
NOTES TO THE ACCOUNTS
Valuation of Financial Assets and Liabilities
Accounting Classification and Fair Values
The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value infomraton for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.
The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy.
GROUP COMPANY
Carrying amount Fair value Carrying amount Fair value | |||||||||||
31 March 2025 | Classification | (Rs.'000) | Level 1 | Level 2 | Level 3 | Total | (Rs.'000) | Level 1 | Level 2 | Level 3 | Total |
Financial Assets measured at Fair value | |||||||||||
Investment in Unquoted Shares | Fair value through OCI | 468,749 | - | - | 468,749 | 468,749 | 468,749 | - | - | 468,749 | 468,749 |
Investment in Quoted Shares | Fair value through P&L | - | - | - | - | - | - | - | - | - | - |
Investment in Unit Trust | Fair value through P&L | 4,254,534 | 4,254,534 | - | - | 4,254,534 | 1,655,123 | 1,655,123 | - | - | 1,655,123 |
Investment Fund | Fair value through P&L | 5,127 | - | 5,127 | - | 5,127 | - | - | - | - | - |
4,728,409 | 4,254,534 | 5,127 | 468,749 | 4,728,409 | 2,123,872 | 1,655,123 | - | 468,749 | 2,123,872 | ||
Financial Assets not measured at Fair value | |||||||||||
Trade and other receivables ** | Amortized cost | 9,796,632 | - | - | - | 9,796,632 | 18,193 | - | - | - | 18,193 |
Investment in Debentures | Amortized cost | 104,170 | - | - | - | 104,170 | 104,170 | - | - | - | 104,170 |
Short term invetsment | Amortized cost | 235,000 | - | - | - | 235,000 | 235,000 | - | - | - | 235,000 |
Amounts due from related parties ** | Amortized cost | 326,356 | - | - | - | 326,356 | 9,459 | - | - | - | 9,459 |
Cash & cash equivalents ** | Amortized cost | 5,875,414 | - | - | - | 5,875,414 | 288,928 | - | - | - | 288,928 |
16,337,572 | - | - | - | 16,337,572 | 655,750 | - | - | - | 655,750 | ||
Financial Liabilities not measured at Fair | value | ||||||||||
Loans and borrowings *** | Other financial liabilities | 6,870,892 | - | - | - 6,870,892 | 29,763 | - | - | - 29,763 | ||
Bank overdraft ** | Other financial liabilities | 749,144 | - | - | - 749,144 | - | - | - | - - | ||
Trade and other payables ** | Other financial liabilities | 9,209,949 | - | - | - 9,209,949 | 193,856 | - | - | - 193,856 | ||
Amounts due to related parties ** | Other financial liabilities | - | - | - | - - | 2 | - | - | - 2 | ||
16,829,985 | - | - | - 16,829,985 | 223,621 | - | - | - 223,621 | ||||
GROUP | COMPANY | ||||||||||
Fair value Fair value Carrying amount Carrying amount | |||||||||||
31 March 2024 Classification | (Rs.'000) | Level 1 | Level 2 | Level 3 | Total | (Rs.'000) | Level 1 | Level 2 | Level 3 | Total | |
Financial Assets measured at Fair value | |||||||||||
Investment in Unquoted Shares Fair value through OCI | 670,469 | - | - | 670,469 | 670,469 | 670,469 | - | - | 670,469 | 670,469 | |
Investment in Quoted Shares Fair value through P&L | 7,549 | 7,549 | - | - | 7,549 | 7,549 | 7,549 | - | - | 7,549 | |
Investment in Unit Trust Fair value through P&L | 1,545,256 | 1,545,256 | - | - | 1,545,256 | 621,226 | 621,226 | - | - | 621,226 | |
Investment Fund Fair value through P&L | 51,393 | - | 51,393 | - | 51,393 | - | - | - | - | - | |
2,274,667 | 1,552,805 | 51,393 | 670,469 | 2,274,667 | 1,299,244 | 628,775 | - | 670,469 | 1,299,244 | ||
Financial Assets not measured at Fair value | |||||||||||
Trade and other receivables ** Amortized cost | 9,782,520 | - | - | 9,782,520 | 44,017 | - | 44,017 | ||||
Investment in Debentures Amortized cost | 104,206 | - | - | 104,206 | 104,206 | - | 104,206 | ||||
Short term invetsment Amortized cost | 225,000 | - | - | 225,000 | 225,000 | - | 225,000 | ||||
Amounts due from related parties ** Amortized cost | 31,749 | - | - | 31,749 | 257,990 | - | 257,990 | ||||
Cash & cash equivalents ** Amortized cost | 5,403,789 | - | - | 5,403,789 | 723,291 | - | 723,291 | ||||
15,547,264 | - | - | - | 15,547,264 | 1,354,504 | - | - | - | 1,354,504 | ||
Financial Liabilities not measured at Fair value | |||||||||||
Loans and borrowings *** Other financial liabilities | 6,988,010 | - | - | 6,988,010 | - | - | - | - | |||
Bank overdraft ** Other financial liabilities | 2,689,245 | - | - | 2,689,245 | - | - | - | - | |||
Trade and other payables ** Other financial liabilities | 7,603,511 | - | - | 7,603,511 | 97,345 | - | - | 97,345 | |||
Amounts due to related parties ** Other financial liabilities | - | - | - | - | 282 | - | - | 282 | |||
17,280,766 | - | - | - | 17,280,766 | 97,627 | - | - | 97,627 | |||
** Classes of financial instruments that are not carried at fair value and of which carrying amounts are a reasonable approximation of fair value. This includes trade receivables, cash and cash equivalents, trade payable, other payables, amounts due to and due from related parties and bank overdraft. The carrying amounts of these financial assets and
liabilities are a reasonable approximation of fair values due to their short term nature.
*** Discounted cash flows: The valuation model considers the present value of expected payments, discounted using a risk-adjusted discount rate.
Page 15
8.2. Measurement of Fair Values
Financial Assets and Liabilities measured or disclosed at Fair Value
The fair value of the financial assets and liabilities is included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale.
The Group measures the fair value using the following fair value hierarchy, which reflects the significance of the inputs used in making the measurement. An analysis of the fair value measurement of financial and non-financial assets and liabilities are provided below:
Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.When available, the Group measures the fair value of an instrument using active quoted prices or dealer price quotations (assets and long positions are measured at a bid price; liabilities and short positions are measured at an ask price), without any deduction for transaction costs. A market is regarded as active if transactions for asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).This category includes instruments valued using:
quoted prices in active markets for similar instruments,
quoted prices for identical or similar instruments in markets that are considered to be less active, or
other valuation techniques in which almost all significant inputs are directly or indirectly observable from market data.
This category includes all instruments for which the valuation technique includes inputs not based on observable data and the unobservable inputs have a significant effect on the instrument's valuation.
8.2.a Valuation techniques and significant unobservable inputsThe following valuation techniques used in measuring Level 2 and Level 3 fair values at 31 March 2025 and 31 March 2024 for financial instruments measured at fair value in the statement of financial position, as well as the significant unobservable inputs used.
Unquoted equity instruments - Discounted cash flowsThe valuation model considers the present value of expected net cash flows from those investments discounted using a risk adjusted discount rate. The expected cash flows are derived based on the budgeted cash flow forecasts of those investments determined by considering the sensible probability of the forecast EBITDA.
Interest rate swaps/Cross currency swaps - Swap modelsThe fair value is calculated as the present value of the estimated future cash flows. Estimates of future floating-rate cash flows are based on quoted swap rates, futures prices and interbank borrowing rates. Estimated cash flows are discounted using a yield curve constructed from similar sources and which reflects the relevant benchmark interbank rate used by market participants for this purpose when pricing interest rate swaps. The fair value estimate is subject to a credit risk adjustment that reflects the credit risk of the Group and of the counterparty; this is calculated based on credit spreads derived from current credit default swap or bond prices.
Those assumptions for assets categorised as Level 3 has been described under respective notes to the financial Statements as at 31 March 2024.
During the reporting period ended 31 March 2025 and 31 March 2024, there were no transfers between Level 1 and Level 2 fair value measurements.
Page 16
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS
Comparatives
The presentation and classification of the Financial Statements of the previous periods have been amended, where relevant, for better presentation and
to be comparable with those of the current period.
Stated capital is represented by shares in issue as given below:
No. of shares as at
31st March 2025
31 March 2024
Ordinary shares
1,967,894,516
491,973,629
SUN has subdivided the ordinary shares of the Company, amounting to four hundred and ninety one million nine hundred and seventy three thousand six hundred and twenty nine (491,973,629) ("Pre-Subdivision Shares") into one billion nine hundred and sixty seven million eight hundred and ninety four thousand five hundred and sixteen (1,967,894,516) ordinary shares ("Post-Subdivision Shares") on the basis of one (01) Pre-Subdivision share held by each shareholder into four (4) ordinary shares.
Dividend
2024/25 (Interim)
RS '000
2023/24 (Final)
RS '000
2023/24 (Interim)
RS '000
Dividend (Rs)
737,060
983,947
491,974
No of ordinary shares
491,974
491,974
491,974
Dividend per share (cash
- After share subdivision)
0.38
0.50
0.25
Commitments & contingencies
There has not been significant change in the nature of the contingent liabilities, which were disclosed in the Annual Report for the year ended 31st
March 2024.
Income tax
Tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in Statement of Profit or Loss except to the extent that it
relates to a business combination, or items recognized directly in equity or in Other Comprehensive Income.
The Group has determined that interest and penalties relating to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them under LKAS 37 Provisions, Contingent Liabilities and Contingent Assets.
Earnings per share
The earnings per share is computed on the profit attributable to ordinary shareholders after tax and non-controlling interest divided by the number of ordinary shares as at the reporting date. Further there was no dilution of ordinary shares outstanding at any time during the period. Therefore, diluted earnings per share is the same as basic earning per share.
Net Assets per share
Net assets per share has been calculated, for all periods, based on the number of shares issued as at the reporting date.
The interim Financial Statements are not audited.
Page 17
SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS | |||
SHAREHOLDER INFORMATION | Audited | ||
Market price per share | Period ended | Year ended | |
31st March 2025 | 31st March 2024 | ||
Highest price | Rs. 100.75* | Rs. 61.50 * | |
Lowest price | 19.80 | 50.00 * | |
Last traded price | 21.50 | 59.50 * | |
TWENTY (20) LARGEST SHAREHOLDERS AS AT | 31 March 2025 | ||
Name | No of Shares | % | |
Held | |||
1. Lamurep Investments Limited Account No.04 & 01 | 1,085,816,556 | 55.18% | |
2. Akbar Brothers Pvt Ltd A/C No 1 | 196,967,420 | 10.01% | |
3. Deepcar Limited | 185,056,304 | 9.40% | |
4. Citibank Newyork S/A Norges Bank Account 2 | 52,918,548 | 2.69% | |
5. Ceylon Property Development Limited | 43,663,504 | 2.22% | |
6. Thread Capital (Private) Limited | 35,779,668 | 1.82% | |
7. Mr. V.Govindasamy | 24,318,000 | 1.24% | |
8. Seylan Bank PLC/ Mohamed Nayazdeen | 23,323,492 | 1.19% | |
9. Perera And Sons Bakers Pvt Limited | 17,600,000 | 0.89% | |
10. Rubber Investment Trust Ltd A/C No 01 | 14,158,916 | 0.72% | |
11. Mr.Hanif Yusoof & NDB Wealth Management | 13,267,979 | 0.67% | |
12. Ranavav Holdingd (Pvt) Ltd & Ranavav Holdings (Pvt) Ltd | 10,946,824 | 0.56% | |
13. Ceylon Guardian Investment Trust PLC A/C # 02 | 9,977,108 | 0.51% | |
14. Asia Securities (Pvt) Ltd (Trading Account) | 9,322,880 | 0.47% | |
15. DFCC Bank PLC A/C/ No 2 & A/C/No 1 | 6,930,120 | 0.35% | |
16. Union Assurance PLC - Universal Life Fund | 6,801,967 | 0.35% | |
17. Ceylon Investment PLC A/C 02 | 6,520,000 | 0.33% | |
18. AFC Umbrella Fund- AFC Asia Frontier Fund | 5,996,044 | 0.30% | |
19. Invenco Capital Private Limited | 5,114,819 | 0.26% | |
20. National Savings Bank | 4,897,842 | 0.25% | |
Sub Total | 1,759,377,991 | 89.40% | |
Others | 208,516,525 | 10.60% | |
Total | 1,967,894,516 | 100.00% | |
PUBLIC SHARE HOLDING | Requirement by CSE | As at 31 December 2024 |
Option | 3 | 3 |
Float adjusted market capitalization | Above Rs.5,000,000,000/- | 15,423,373,269 |
The percentage of shares held by the public | 7.5% | 31.35% |
Number of shareholders representing public holding | 500 | 7,000 |
The number of shares held by the Board of Directors are as follows: | As at | As at |
31st March 2025 | 31st March 2024 | |
Mr. V. Govindasamy | 24,318,000 | 6,079,500 * |
Mr.G.Sathasivam | 36,660 | 9,165 * |
Mr. S.G. Sathasivam | 12,216 | 3,054 * |
* Figures indicated the results prior to the share subdivision. |
Page 18
CORPORATE INFORMATION
Name of Company
Sunshine Holdings PLC
Legal Form
Public Limited Liability Company
(Incorporated in 1973 and listed in the Colombo Stock Exchange)
Company Registration Number
PQ13
Principal Activities
Managing a portfolio of businesses
Registered Office
No. 60, Dharmapala Mawatha, Colombo 03
Directors
Mr. D. A. Cabraal Mr. V. Govindasamy Mr. S.G. Sathasivam
Mr. A. Talwatte (Resigned with effect from 1st of April 2025)
Mr. G. Sathasivam Mr. S. Shishoo
Mr. Sudarshan Jain Mr. S. Renganathan
Mr. Tyeabally Akbarally Mr. Reyaz Mihular
Ms. Aruni Goonetilleke Mr. Aruna Deepthikumara
Secretaries
Corporate Services (Private) Limited No. 216, De Seram Place,
Colombo 10
Tel: 011 4 605 100
Auditors
KPMG
Chartered Accountants
32A, Sri Mohamed Macan Marker Mawatha, Colombo 03
Lawyers
F J & G de Saram (Attorney- at -Law) No.216, de Saram Place
Colombo 10
Nithya Partners Attorneys-at-Law No. 97/A, Galle Road Colombo 03
Bankers
Hatton National Bank PLC National Development Bank PLC MCB Bank Limited
Standard Chartered Bank Ltd. Seylan Bank PLC
Nations Trust Bank PLC Commercial Bank PLC Indian Overseas Bank
Hongkong and Shanghai Banking Corporation Limited DFCC Bank PLC
Indian Bank
Credit Ratings
The Company has been assigned a national long-term rating of 'AA+(lka)'; outlook stable by Fitch Ratings
Lanka Limited
Page 19
